North Asia likely to see a deceleration in earnings growth in 2022: Morgan Stanley; At stake is not when the Fed will hike rates, but at which pace: J.P. Morgan Asset Management; High-quality growth companies combined with select cyclical stocks could prove winner in 2022: UBP; US scrutiny puts China’s biotech sector under stress: UBS GWM North Asia likely to see…
Have a confidential tip? Get in touch [email protected]